ARCHIVES

Phase III Trial Fails to Extend OS After Meeting Primary Endpoint Of Durable Response Rate

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Two Doses of the Vaccine Cervarix Can Be As Effective As Three

September 30, 2011

Medicare Cuts Proposed In budget reduction Amendment For FY94

November 19, 1993

In Brief: Chamberlain, Kupchella Lead Educators; Mattel Donates $25 Million To UCLA Children’s

November 20, 1998

New Organ Systems Program Coordinating Center RFA Released

April 1, 1983

Merritt To Head Nursing Center’s Implementation; Nurse Research And Training Opportunities Varied

January 10, 1986

HOP Development Proceeding Guidelines For New, Revision Of Existing Control Grants Being Written

July 24, 1981